Non-Pharmacological Treatments in Lewy Body Disease: A Systematic Review.

IF 2.2 4区 医学 Q3 CLINICAL NEUROLOGY Dementia and Geriatric Cognitive Disorders Pub Date : 2023-01-01 DOI:10.1159/000529256
Lucia Guidi, Stefania Evangelisti, Andrea Siniscalco, Raffaele Lodi, Caterina Tonon, Micaela Mitolo
{"title":"Non-Pharmacological Treatments in Lewy Body Disease: A Systematic Review.","authors":"Lucia Guidi,&nbsp;Stefania Evangelisti,&nbsp;Andrea Siniscalco,&nbsp;Raffaele Lodi,&nbsp;Caterina Tonon,&nbsp;Micaela Mitolo","doi":"10.1159/000529256","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Lewy body disease (LBD) is the second most common neurodegenerative disorder in patients older than 65 years. LBD is characterized by heterogeneous symptoms like fluctuation in attention, visual hallucinations, Parkinsonism, and REM sleep behaviour disorders. Considering the relevant social impact of the disease, identifying effective non-pharmacological treatments is becoming a priority. The aim of this systematic review was to provide an up-to-date literature review of the most effective non-pharmacological treatments in patients with LBD, focussing on evidence-based interventions.</p><p><strong>Methods: </strong>Following PRISMA criteria, we carried out a systematic search through three databases (PubMed, Cochrane Libraries, and PEDro) including physical therapy (PT), cognitive rehabilitation (CR), light therapy (LT), transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), deep brain stimulation (DBS). All studies were qualitatively assessed using standardized tools (CARE and EPHPP).</p><p><strong>Results: </strong>We obtained a total of 1,220 studies of which 23 original articles met eligibility criteria for inclusion. The total number of LBD patients included was 231; mean age was 69.98, predominantly men (68%). Some PT studies highlighted improvements in motor deficits. CR produced significant improvements in mood, cognition, and patient's quality of life and satisfaction. LT outlined a partial trend of improvements in mood and sleep quality. DBS, ECT, and TMS showed some partial improvements mainly on neuropsychiatric symptoms, whereas tDCS provided partial improvements in attention.</p><p><strong>Conclusion: </strong>This review highlights the efficacy of some evidence-based rehabilitation studies in LBD; however, further randomized controlled trials with larger samples are needed to provide definitive recommendations.</p>","PeriodicalId":11126,"journal":{"name":"Dementia and Geriatric Cognitive Disorders","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and Geriatric Cognitive Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000529256","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Lewy body disease (LBD) is the second most common neurodegenerative disorder in patients older than 65 years. LBD is characterized by heterogeneous symptoms like fluctuation in attention, visual hallucinations, Parkinsonism, and REM sleep behaviour disorders. Considering the relevant social impact of the disease, identifying effective non-pharmacological treatments is becoming a priority. The aim of this systematic review was to provide an up-to-date literature review of the most effective non-pharmacological treatments in patients with LBD, focussing on evidence-based interventions.

Methods: Following PRISMA criteria, we carried out a systematic search through three databases (PubMed, Cochrane Libraries, and PEDro) including physical therapy (PT), cognitive rehabilitation (CR), light therapy (LT), transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), deep brain stimulation (DBS). All studies were qualitatively assessed using standardized tools (CARE and EPHPP).

Results: We obtained a total of 1,220 studies of which 23 original articles met eligibility criteria for inclusion. The total number of LBD patients included was 231; mean age was 69.98, predominantly men (68%). Some PT studies highlighted improvements in motor deficits. CR produced significant improvements in mood, cognition, and patient's quality of life and satisfaction. LT outlined a partial trend of improvements in mood and sleep quality. DBS, ECT, and TMS showed some partial improvements mainly on neuropsychiatric symptoms, whereas tDCS provided partial improvements in attention.

Conclusion: This review highlights the efficacy of some evidence-based rehabilitation studies in LBD; however, further randomized controlled trials with larger samples are needed to provide definitive recommendations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
路易体病的非药物治疗:系统综述。
简介:路易体病(LBD)是65岁以上患者中第二常见的神经退行性疾病。LBD的特点是异质性症状,如注意力波动、视觉幻觉、帕金森病和快速眼动睡眠行为障碍。考虑到该疾病的相关社会影响,确定有效的非药物治疗正在成为一个优先事项。本系统综述的目的是为LBD患者最有效的非药物治疗提供最新的文献综述,重点是循证干预。方法:按照PRISMA标准,我们通过PubMed、Cochrane Libraries和PEDro三个数据库进行系统检索,包括物理治疗(PT)、认知康复(CR)、光疗(LT)、经颅直流电刺激(tDCS)、经颅磁刺激(TMS)、电休克治疗(ECT)、深部脑刺激(DBS)。使用标准化工具(CARE和EPHPP)对所有研究进行定性评估。结果:我们共获得1220项研究,其中23篇原创文章符合入选标准。纳入LBD患者总数为231例;平均年龄69.98岁,以男性为主(68%)。一些PT研究强调了运动缺陷的改善。CR显著改善了患者的情绪、认知、生活质量和满意度。LT概述了情绪和睡眠质量改善的部分趋势。DBS、ECT和TMS主要对神经精神症状有部分改善,而tDCS对注意力有部分改善。结论:本综述强调了一些循证康复研究在LBD中的疗效;然而,需要进一步的大样本随机对照试验来提供明确的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.70
自引率
0.00%
发文量
46
审稿时长
2 months
期刊介绍: As a unique forum devoted exclusively to the study of cognitive dysfunction, ''Dementia and Geriatric Cognitive Disorders'' concentrates on Alzheimer’s and Parkinson’s disease, Huntington’s chorea and other neurodegenerative diseases. The journal draws from diverse related research disciplines such as psychogeriatrics, neuropsychology, clinical neurology, morphology, physiology, genetic molecular biology, pathology, biochemistry, immunology, pharmacology and pharmaceutics. Strong emphasis is placed on the publication of research findings from animal studies which are complemented by clinical and therapeutic experience to give an overall appreciation of the field.
期刊最新文献
Toolkit to Examine Lifelike Language (TELL) v.2.0: Optimizing speech biomarkers of neurodegeneration. Current Advances in Computerised Cognitive Assessment for Mild Cognitive Impairment and Dementia in Older Adults: A systematic Review. Risperidone for the Treatment of Dementia-Related Psychosis: A Systematic Review and Meta-Analysis. Differential Item Functioning and Clinical Utility of the Subjective Memory Complaints Questionnaire in a Multi-Ethnic Cohort. Efficacy of acetylcholinesterase inhibitors in the logopenic variant of primary progressive aphasia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1